Cryo-Cell International (STU:ZCY) Total Liabilities: €67.17 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ZCY Cryo-Cell International Inc STU:ZCY
57 GF Score
Price €2.76
GF Value €4.36
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Total Liabilities?

Cryo-Cell International STU:ZCY -8.61% 57 Total Liabilities is €67.17 Mil as of May. 2026. GuruFocus rates STU:ZCY with a GF Score™ of 57/100 and a GF Value™ of €4.36 (Possible Value Trap). The stock has 4 warning signs investors should review.

Cryo-Cell International's Total Liabilities for the quarter that ended in May. 2026 was €67.17 Mil.

Cryo-Cell International's quarterly Total Liabilities declined from Nov. 2025 (€69.49 Mil) to Feb. 2026 (€67.08 Mil) but then increased from Feb. 2026 (€67.08 Mil) to May. 2026 (€67.17 Mil).

Cryo-Cell International's annual Total Liabilities increased from Nov. 2023 (€66.76 Mil) to Nov. 2024 (€73.38 Mil) but then declined from Nov. 2024 (€73.38 Mil) to Nov. 2025 (€69.49 Mil).

Cryo-Cell International Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Total Liabilities Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.48 65.15 66.76 73.38 69.49

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.96 67.00 69.49 67.08 67.17
STU:ZCY
57GF Score
Cryo-Cell International Inc STU:ZCY
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cryo-Cell International's Total Liabilities for the fiscal year that ended in Nov. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.121+(7.478+0.797
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+44.093+0+0)
=69.49

Total Liabilities=Total Assets (A: Nov. 2025 )-Total Equity (A: Nov. 2025 )
=53.396--16.094
=69.49

Cryo-Cell International's Total Liabilities for the quarter that ended in May. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.636+(7.142+0.78900000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+45.598+0+0)
=67.17

Total Liabilities=Total Assets (Q: May. 2026 )-Total Equity (Q: May. 2026 )
=51.964--15.201
=67.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €67.17 Mil mean?
Cryo-Cell International (STU:ZCY) has a Total Liabilities of €67.17 Mil as of May. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryo-Cell International and its competitors.
Is Cryo-Cell International's Total Liabilities too high?
Cryo-Cell International's current Total Liabilities is €67.17 Mil. Overall, Cryo-Cell International has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Total Liabilities compare to CCM and CDIX?
Cryo-Cell International's Total Liabilities of €67.17 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryo-Cell International and its competitors. Cryo-Cell International's current Total Liabilities is €67.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (STU:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.36, compared to a current price of €2.76 — trading 36.7% below its estimated fair value. The current Total Liabilities is €67.17 Mil. Cryo-Cell International's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cryo-Cell International (STU:ZCY), the current Total Liabilities is €67.17 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (STU:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.76 is trading 36.7% below its estimated GF Value™ of €4.36. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for STU:ZCY:

  • Total Liabilities: €67.17 Mil
  • GF Value™: €4.36 vs. price of €2.76 (36.7% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the STU:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryo-Cell International Business Description

Other Exchanges CCEL:USAZCY:Germany
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
57GF Score

Get the complete analysis for STU:ZCY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.76
Price
€4.36
GF Value